A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer-Reference-Cited by-同舟云学术

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Published:2018-03-26 Issue:11 Volume:124 Page:2337-2346
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pishvaian Michael J.¹^ORCID,Slack Rebecca S.²,Jiang Wei³,He A. Ruth¹,Hwang Jimmy J.³,Hankin Amy¹,Dorsch-Vogel Karen¹,Kukadiya Divyesh¹,Weiner Louis M.¹,Marshall John L.¹,Brody Jonathan R.⁴⁵⁶

Affiliation:

1. Lombardi Comprehensive Cancer Center; Georgetown University Medical Center; Washington DC

2. The University of Texas MD Anderson Cancer Center; Houston Texas

3. Carolinas Medical Center; Charlotte North Carolina

4. Jefferson Pancreas, Biliary, and Related Cancer Center; Thomas Jefferson University; Philadelphia Pennsylvania

5. Department of Surgery; Thomas Jefferson University; Philadelphia Pennsylvania

6. Sidney Kimmel Cancer Center; Thomas Jefferson University; Philadelphia Pennsylvania

Funder

Ruesch Center for the Cure of Gastrointestinal Cancers at the Lombardi Comprehensive Cancer Center

AbbVie, Inc

National Institutes of Health

Pancreatic Cancer Action Network-American Association for Cancer Research Acceleration Network

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase;Cherney;Proc Natl Acad Sci U S A.,1987

2. Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: influences on genomic stability, chromatin organization, and carcinogen cytotoxicity;Ding;Cancer Res.,1994

3. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology;Ratnam;Clin Cancer Res.,2007

4. Cancer chromosomes in crisis;DePinho;Nat Genet.,2004

5. Telomeres, stem cells, senescence, and cancer;Sharpless;J Clin Invest.,2004

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer;International Journal of Molecular Sciences;2024-06-05

2. Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions;Cancer Treatment Reviews;2024-04

3. PARP Inhibitors in Colorectal Malignancies: A 2023 Update;Reviews on Recent Clinical Trials;2023-12-06

4. Epigenetically Downregulated Breast Cancer Gene 2 through Acetyltransferase Lysine Acetyltransferase 2B Increases the Sensitivity of Colorectal Cancer to Olaparib;Cancers;2023-11-25

5. Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy;Frontiers in Oncology;2023-11-07